|
DOVE
LAB
William
F. Dove and colleagues
McArdle Laboratory for Cancer Research
University of Wisconsin - Madison
1400 University Avenue
Madison, WI 53706-1599
Phone: (608) 262-0982
CV
for William F. Dove
Research
Description:
Our laboratory studies the genetic, cellular, and molecular interactions
involved in cancer of the self-renewing mammalian intestinal epithelium.
To pursue this goal, we have established two complementary animal
models for familial colon cancer - the Min (Multiple intestinal
neoplasia) mouse and Pirc (Polyposis in the rat colon) rat kindreds.
By manipulating the genetic background of these kindreds, we can
discover genes that quantitatively or qualitatively influence the
colon cancer phenotype. The emergent power to analyze the genome,
transcriptome, and proteome of the mouse, rat, and human connects
these biological studies in experimental animals to the molecular
players that control this disease in humans.
The
power to phenotype the neoplastic process is greatly enhanced by
achieving both spatial and temporal resolution. Spatial resolution
by immunohistochemistry, in situ hybridization, or somatic lineage
marking illuminates issues in cellular/genetic interactions involving
the neoplastic lineage and the microenvironment. Imaging tumors
over time in live animals by either optical endoscopy or virtual
colonoscopy addresses issues in tumor progression and regression,
spontaneous or induced by host factors, environmental agents, or
drugs.
A doctoral
or postdoctoral member of our laboratory would learn the biology
of the laboratory mouse and rat, including the assay of molecular
markers of neoplastic development by immunohistochemistry or in
situ hybridization, objective assessment of neoplastic growth and
regression, and investigation of the autonomy of gene action by
tissue grafting, chimerism and mosaicism. Group members can broaden
their research capacity through our ongoing research interactions
with collaborators on campus. Working with biostatisticians, we
become familiar with the genetics of quantitative modifiers of tumor
susceptibility. Working with faculty in radiology and medical physics,
we explore new imaging methods. With the Biotechnology Center, we
engage the evolving power of mass spectrometry in the analysis of
protein markers expressed in the plasma of tumor-bearing animals.
Altogether,
uniquely complementing other investigations worldwide, our Wisconsin
team hopes to achieve a deep understanding of the biology of colon
cancer and thereby to impact its management in humans.
|